Rituximab in New Onset Type 1 Diabetes

Clinical trial NCT00279305 · COMPLETED

Trial details

NCT number: NCT00279305
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Type 1 Diabetes Mellitus

Start date: 2005-08-01
Primary completion: 2009-04-01
Enrollment: 87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.